HDFC Mid Cap Fund Regular-Growth
The fund is rated 4.5 stars. The strongest areas were investment selection within each asset type and investment selection within each industry, while balance between returns and downside risk provided some support. Above-average fund size of Rs 105,142.69 crore was a minor drawback.
This fund has a good track record with Asset Selection/Timing, a good track record with Stock Selection/Timing. It is important to note, however, that this fund has a 105142.694 AUM and a 1.3 expense ratio. Considering all these factors, we have rated this fund as 4.5 star.
हमारा स्कोर दीर्घकालिक प्रदर्शन, जोखिम और निरंतरता को तौलता है — केवल पिछले रिटर्न को नहीं।
रिटर्न
25 Sep 2026 तक
जोखिम अनुपात
31 Aug 2026 तक
पोर्टफोलियो
31 Aug 2026 तक
मार्केट-कैप विभाजन
सेक्टर आवंटन
होल्डिंग्स (80)
| होल्डिंग | फंड का % | मूल्य | शेयर |
|---|---|---|---|
| Others | 6.91% | ₹7,484.03 Cr | — |
| The Federal Bank Ltd. | 4.21% | ₹4,559.52 Cr | 12,78,25,000 |
| AU Small Finance Bank Ltd. | 3.98% | ₹4,316.27 Cr | 3,97,37,347 |
| Max Financial Services Ltd. | 3.79% | ₹4,108.03 Cr | 2,61,14,231 |
| Ipca Laboratories Ltd. | 3.30% | ₹3,575.69 Cr | 1,81,05,658 |
| Glenmark Pharmaceuticals Ltd. | 3.07% | ₹3,325.23 Cr | 1,34,08,183 |
| Indian Bank | 3.06% | ₹3,312.3 Cr | 3,68,54,482 |
| Balkrishna Industries Ltd. | 3.02% | ₹3,268.66 Cr | 1,43,41,251 |
| Coforge Ltd. | 2.86% | ₹3,101.16 Cr | 1,56,20,600 |
| Fortis Healthcare Ltd. | 2.69% | ₹2,911.32 Cr | 3,21,01,862 |
फंड विवरण
to generate long-term capital appreciation / income. investment predominantly in Mid-Cap companies.
The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies.
Exit load of 1% if redeemed within 1 year.